Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy

Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy

INTRODUCTION: The need for defining the extension of disease in patients undergoing radical prostatectomy due to prostate adenocarcinoma is a relevant factor cure in such individuals. In order to identify a new independent preoperative factor for predicting the extension of prostate cancer, we asses...

Full description

Bibliographic Details
Main Authors:	Marcos F. Dall'oglio, Alexandre Crippa, Luis C. Oliveira, Joao F. Neves Neto, Katia R. Leite, Miguel Srougi
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2005-10-01
Series:	International Brazilian Journal of Urology
Subjects:	prostatic neoplasms biopsy needle neoplasm staging
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382005000500005

Similar Items

Pathological extension of prostate cancer as defined by gleason score on biopsy
by: Marcos F. Dall'oglio, et al.
Published: (2005-08-01)

Prostate biopsy: is age important for determining the pathological features in prostate cancer?
by: Alberto A. Antunes, et al.
Published: (2005-08-01)

Preoperative determination of prostate cancer tumor volume: analysis through biopsy fragments
by: Alberto A. Antunes, et al.
Published: (2007-08-01)

Can Single Positive Core Prostate Cancer at biopsy be Considered a Low-Risk Disease after Radical Prostatectomy?
by: Ricardo Kupka da Silva, et al.
Published: (2013-12-01)

Quantification of tumor extension in prostate biopsies: importance in the identification of confined tumors
by: Leite Kátia R.M., et al.
Published: (2003-01-01)

Prostate Biopsy: General Consideration and Systematic Biopsy
by: Hyungwoo Ahn
Published: (2023-11-01)

Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy
by: Katia Ramos Moreira Leite, et al.
Published: (2008-01-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

Analysis of risk factors of involvement of seminal vesicles in patients with prostate cancer undergoing radical prostatectomy
by: Marcos F. Dall'Oglio, et al.
Published: (2004-12-01)

Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy
by: Yoshiro Sakamoto, et al.
Published: (2014-09-01)

Does tumor extent on needle prostatic biopsies influence the value of perineural invasion to predict pathologic stage > T2 in radical prostatectomies?
by: Athanase Billis, et al.
Published: (2010-08-01)

Predictive value of PSA velocity over early clinical and pathological parameters in patients with localized prostate cancer who undergo radical retropubic prostatectomy
by: Martinez Carlos A.L., et al.
Published: (2004-01-01)

Efficiency of 6- and 12-punctures biopsies to detect prostate cancer in patients with PSA< 10 ng/mL and normal digital rectal examination
by: Luiz E. Slongo, et al.
Published: (2003-02-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Interobserver agreement of gleason score and modified gleason score in needle biopsy and in surgical specimen of prostate cancer
by: Sergio G. Veloso, et al.
Published: (2007-10-01)

Prostate biopsies containing prostate intraepithelial neoplasia and atypical small acinar proliferation: what to do?
by: Fernando Korkes, et al.
Published: (2009-12-01)

Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer
by: Thiago N. Valette, et al.
Published: (2015-06-01)

Evaluation of concordance between histopathological prognostic findings from prostate needle biopsy samples and serum prostate-specific antigen levels
by: Cengiz Kocak
Published: (2019-03-01)

Serum PSA and cure perspective for prostate cancer in males with nonpalpable tumor
by: Marcos F. Dall'Oglio, et al.
Published: (2005-10-01)

Fusion prostate biopsy: tips and tricks to improve rigid registration
by: Angelo Naselli, et al.
Published: (2022-05-01)

Is the periprostatic anesthetic blockade advantageous in ultrasound-guided prostate biopsy?
by: André P. Vanni, et al.
Published: (2004-04-01)

The Prostate Problem You Can’t Put Your Finger on the Normal Way: A Case of Perineal Prostate Cancer Post Transperineal Prostate Biopsy
by: Kevin Yinkit Zhuo, et al.
Published: (2023-05-01)

Primary lymphoma of the prostate: a rare cause of urinary obstruction
by: Alberto A. Antunes, et al.
Published: (2004-10-01)

Prostatic atrophy: clinicopathological significance
by: Athanase Billis
Published: (2010-08-01)

Age impact in clinicopathologic presentation and the clinical evolution of prostate cancer in patients submitted to radical prostatectomy
by: Alberto A. Antunes, et al.
Published: (2006-02-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Microvascular invasion is an independent prognostic factor in patients with prostate cancer treated with radical prostatectomy
by: Alberto A. Antunes, et al.
Published: (2006-12-01)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
by: Alexandros Fiamegos, et al.

Three different techniques for administering analgesia during transrectal ultrasound-guided prostate biopsy: a comparative study
by: Volkan Izol, et al.
Published: (2012-02-01)

Continued administration of antithrombotic agents during transperineal prostate biopsy
by: Toko Asano, et al.
Published: (2015-02-01)

Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy
by: Renato Caretta Chambó, et al.
Published: (2015-02-01)

Transperineal ultrasound-guided prostate biopsy: what the radiologist needs to know
by: Jack Power, et al.
Published: (2022-04-01)

Gleason score and laterality concordance between prostate biopsy and prostatectomy specimens
by: Kenneth G. Nepple, et al.
Published: (2009-10-01)

Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy
by: Victor Srougi, et al.
Published: (2011-08-01)

Cystectomy with orthotopic reconstruction following radical retropubic prostatectomy
by: Ari Miotto Jr, et al.
Published: (2004-04-01)

Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
by: Sangjun Yoo, et al.
Published: (2020-06-01)

Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL
by: Katia R. Leite, et al.
Published: (2008-06-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Computed tomography guided needle biopsy: experience from 1,300 procedures
by: Rubens Chojniak, et al.

Comparison between Two Types of 22-Gauge Fine-Needle Biopsy for Solid Pancreatic Tumors
by: Cesar Jaurrieta-Rico, et al.
Published: (2022-03-01)